-
-
-
-
-
-
-
Opus Genetics (IRD) Reiterated at Market Outperform by Citizens: Focus on Viatris
-
-
-
-
-
-
-
BTIG on Opus Genetics (IRD): 'the path from here to BLA submission seems clear'
-
-
-
-
-
-
-
Guggenheim Starts Opus Genetics (IRD) at Buy
-
-
-
-
-
-
-
Opus Genetics (IRD) files for 7.37M share offering by selling stockholders
-
-
-
-
-
-
-
FDA accepts Opus Genetics presbyopia drug application
-
-
-
-
-
-
-
Piper Sandler Starts Opus Genetics (IRD) at Overweight
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)
-
479,047 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


